ClinicalTrials.Veeva

Menu

A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer

Lilly logo

Lilly

Status and phase

Completed
Phase 2

Conditions

Non Small Cell Lung Cancer

Treatments

Dietary Supplement: Vitamin B12
Drug: pemetrexed
Dietary Supplement: Folic Acid
Drug: dexamethasone
Dietary Supplement: Folic acid

Study type

Interventional

Funder types

Industry

Identifiers

NCT00609518
H3E-CR-S111 (Other Identifier)
11652 (Registry Identifier)

Details and patient eligibility

About

Chemotherapy for patients with non-squamous non-small cell lung cancer. Patients are given folic acid, vitamin B12 and steroids, both before and during treatment, to reduce the side effects associated with pemetrexed. The aim is whether it is possible to simplify the folic acid and steroid schedule without increasing toxicity.

Enrollment

111 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologic or cytologic diagnosis of non-small cell lung cancer (NSCLC) with locally advanced or metastatic disease (Stage IIIA, IIIB or IV)that is of non-squamous histology
  • Patients must have failed only one prior chemotherapy regime and must be considered eligible for further chemotherapy following progression of their disease.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2
  • Adequate organ function

Exclusion criteria

  • Concurrent administration of any other anti-tumor therapy
  • Other co-existing malignancies
  • Pregnancy or breast feeding
  • Serious concomitant disorders
  • Inability or unwillingness to take folic acid or vitamin B12 supplementation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

111 participants in 2 patient groups

Standard Vitamin and Steroid Schedule + Pemetrexed
Active Comparator group
Description:
Standard vitamin and steroid schedule that is used with pemetrexed consisting of a minimum of 5 daily doses of folic acid before first pemetrexed dose and dexamethasone on day before, day of, and day after treatment.
Treatment:
Drug: dexamethasone
Dietary Supplement: Folic acid
Drug: dexamethasone
Dietary Supplement: Vitamin B12
Drug: pemetrexed
Simplified Vitamin and Steroid Schedule + Pemetrexed
Experimental group
Description:
Simplified vitamin and steroid schedule to be used with pemetrexed consisting of 2 daily doses of folic acid before first pemetrexed dose and dexamethasone on day of treatment only.
Treatment:
Drug: dexamethasone
Drug: dexamethasone
Dietary Supplement: Vitamin B12
Dietary Supplement: Folic Acid
Drug: pemetrexed

Trial contacts and locations

14

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems